Adc Therapeutics is a biotechnology company focused on the development of next-generation antibody-drug conjugates (ADCs) for the treatment of cancers
The company leverages its proprietary technology platform to create innovative therapies that specifically target and kill cancer cells while sparing healthy tissue, thereby enhancing treatment efficacy and reducing side effects. Adc Therapeutics aims to address unmet medical needs in oncology by advancing its pipeline of drug candidates through clinical trials, and its research efforts are guided by a commitment to improve patient outcomes in various types of malignancies.
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates for patients suffering from hematological malignancies and solid tumors.
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQSGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Gainers Carbon Revolution Public Limited (NASDAQCREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge Capital Acquisition Corp.
